|
1
|
Ren XL, He GY, Li XM, Men H, Yi LZ, Lu GF,
Xin SN, Wu PX, Li YL, Liao WT, et al: MicroRNA-206 functions as a
tumor suppressor in colorectal cancer by targeting FMNL2. J Cancer
Res Clin Oncol. 142:581–592. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burden ST, Hill J, Shaffer JL and Todd C:
Nutritional status of preoperative colorectal cancer patients. J
Hum Nutr Diet. 23:402–407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rasmussen S, Larsen PV, Søndergaard J,
Elnegaard S, Svendsen RP and Jarbøl DE: Specific and non-specific
symptoms of colorectal cancer and contact to general practice. Fam
Pract. 32:387–394. 2015.PubMed/NCBI
|
|
4
|
Cerdán-Santacruz C, Cano-Valderrama O,
Cárdenas-Crespo S, Torres-García AJ and Cerdán-Miguel J: Colorectal
cancer and its delayed diagnosis: Have we improved in the past 25
years? Rev Esp Enferm Dig. 103:458–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zippi M, De Toma G, Minervini G, Cassieri
C, Pica R, Colarusso D, Stock S and Crispino P: Desmoplasia
influenced recurrence of disease and mortality in stage III
colorectal cancer within five years after surgery and adjuvant
therapy. Saudi J Gastroenterol. 23:39–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chaudhry H, Zhou J, Zhong Y, Ali MM,
McGuire F, Nagarkatti PS and Nagarkatti M: Role of cytokines as a
double-edged sword in sepsis. In Vivo. 27:669–684. 2013.PubMed/NCBI
|
|
7
|
Liu M, Zhao X and Ma Y, Zhou Y, Deng M and
Ma Y: Transcription factor c-Maf is essential for IL-10 gene
expression in B cells. Scand J Immunol. 88:e127012018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tabibzadeh S, Becker JL and Parsons AK:
Endometriosis is associated with alterations in the relative
abundance of proteins and IL-10 in the peritoneal fluid. Front
Biosci. 8:a70–a78. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hamzavi M, Tadbir AA, Rezvani G, Ashraf
MJ, Fattahi MJ, Khademi B, Sardari Y and Jeirudi N: Tissue
expression, serum and salivary levels of IL-10 in patients with
head and neck squamous cell carcinoma. Asian Pac J Cancer Prev.
14:1681–1685. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu SQ, Liang W, Wang GL, Li LY, Wang DL
and Chen C: Polymorphisms of the IL-18 promoter and bronchial
asthma. Mol Med Rep. 6:1385–1388. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cornish J, Gillespie MT, Callon KE,
Horwood NJ, Moseley JM and Reid IR: Interleukin-18 is a novel
mitogen of osteogenic and chondrogenic cells. Endocrinology.
144:1194–1201. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu W, Hu M, Wang Y, Sun B, Guo Y, Xu Z,
Li J and Han B: Overexpression of interleukin-18 protein reduces
viability and induces apoptosis of tongue squamous cell carcinoma
cells by activation of glycogen synthase kinase-3β signaling. Oncol
Rep. 33:1049–1056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Long X, Li R, Yang Y and Qiao J:
Overexpression of IL-18 in the proliferative phase endometrium of
patients with polycystic ovary syndrome. Reprod Sci. 24:252–257.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ress AL, Perakis S and Pichler M:
microRNAs and colorectal cancer. Adv Exp Med Biol. 889:89–103.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goldvaser H, Purim O, Kundel Y,
Shepshelovich D, Shochat T, Shemesh-Bar L, Sulkes A and Brenner B:
Colorectal cancer in young patients: Is it a distinct clinical
entity? Int J Clin Oncol. 21:684–695. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng Y and Wu C: Prevalence and trend of
gastrointestinal malignant tumors in the elderly over 75 years old
in China. Zhonghua Wei Chang Wai Ke Za Zhi. 19:481–485. 2016.(In
Chinese). PubMed/NCBI
|
|
17
|
Castells A: Prevention of colorectal
cancer. Med Clin (Barc). 117:69–75. 2001.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hind R, Rew DR and Johnson CD: Surgical
excision alone is adequate treatment for primary colorectal cancer.
Ann R Coll Surg Engl. 74:63–67. 1992.PubMed/NCBI
|
|
19
|
Sio A, Chehal MK, Tsai K, Fan X, Roberts
ME, Nelson BH, Grembecka J, Cierpicki T, Krebs DL and Harder KW:
Dysresgulated hematopoiesis caused by mammary cancer is associated
with epigenetic changes and hox gene expression in hematopoietic
cells. Cancer Res. 73:5892–5904. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mittal SK and Roche PA: Suppression of
antigen presentation by IL-10. Curr Opin Immunol. 34:22–27. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dwivedi S, Goel A, Natu SM, Mandhani A,
Khattri S and Pant KK: Diagnostic and prognostic significance of
prostate specific antigen and serum interleukin 18 and 10 in
patients with locally advanced prostate cancer: A prospective
study. Asian Pac J Cancer Prev. 12:1843–1848. 2011.PubMed/NCBI
|
|
22
|
Amerio P, Frezzolini A, Abeni D, Teofoli
P, Girardelli CR, De Pità O and Puddu P: Increased IL-18 in
patients with systemic lupus erythematosus: Relations with Th-1,
Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a
marker of disease activity but does not correlate with
pro-inflammatory cytokines. Clin Exp Rheumatol. 20:535–538.
2002.PubMed/NCBI
|
|
23
|
Li X, Ren D, Li Y, Xu J, Liu C and Zhao Y:
Increased cancer risk associated with the −607C/A polymorphism in
interleukin-18 gene promoter: An updated meta-analysis including
12,502 subjects. J BUON. 20:902–917. 2015.PubMed/NCBI
|
|
24
|
Jablonska E, Puzewska W, Grabowska Z,
Jablonski J and Talarek L: VEGF, IL-18 and NO production by
neutrophils and their serum levels in patients with oral cavity
cancer. Cytokine. 30:93–99. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haghshenas MR, Hosseini SV, Mahmoudi M,
Saberi-Firozi M, Farjadian S and Ghaderi A: IL-18 serum level and
IL-18 promoter gene polymorphism in Iranian patients with
gastrointestinal cancers. J Gastroenterol Hepatol. 24:1119–1122.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Galizia G, Orditura M, Romano C, Lieto E,
Castellano P, Pelosio L, Imperatore V, Catalano G, Pignatelli C and
De Vita F: Prognostic significance of circulating IL-10 and IL-6
serum levels in colon cancer patients undergoing surgery. Clin
Immunol. 102:169–178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Becker C, Fantini MC, Wirtz S, Nikolaev A,
Lehr HA, Galle PR, Rose-John S and Neurath MF: IL-6 signaling
promotes tumor growth in colorectal cancer. Cell Cycle. 4:217–220.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miteva LD, Stanilov NS, Deliysky TS and
Stanilova SA: Significance of −1082A/G polymorphism of IL-10 gene
for progression of colorectal cancer and IL-10 expression. Tumour
Biol. 35:12655–12664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okamoto M, Azuma K, Hoshino T, Imaoka H,
Ikeda J, Kinoshita T, Takamori S, Ohshima K, Edakuni N, Kato S, et
al: Correlation of decreased survival and IL-18 in bone metastasis.
Intern Med. 48:763–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
